ASTERDM Stock Overview
Aster DM Healthcare Limited operates as a healthcare company in India and internationally.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 3/6 |
Past Performance | 5/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
NewNotes are coming soon
Aster DM Healthcare Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹212.35 |
52 Week High | ₹275.60 |
52 Week Low | ₹158.10 |
Beta | 0.61 |
1 Month Change | -6.70% |
3 Month Change | -19.72% |
1 Year Change | 15.28% |
3 Year Change | 30.04% |
5 Year Change | n/a |
Change since IPO | 16.97% |
Recent News & Updates
Recent updates
Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?
Apr 03Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount?
Mar 02Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186?
Dec 17Is Aster DM Healthcare (NSE:ASTERDM) A Risky Investment?
Dec 02Is There An Opportunity With Aster DM Healthcare Limited's (NSE:ASTERDM) 29% Undervaluation?
Nov 19There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital
Nov 04Aster DM Healthcare (NSE:ASTERDM) Has A Pretty Healthy Balance Sheet
Aug 30Is There Now An Opportunity In Aster DM Healthcare Limited (NSE:ASTERDM)?
Aug 17Is It Too Late To Consider Buying Aster DM Healthcare Limited (NSE:ASTERDM)?
May 04Return Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Appealing
Mar 28Should You Review Recent Insider Transactions At Aster DM Healthcare Limited (NSE:ASTERDM)?
Mar 13Aster DM Healthcare (NSE:ASTERDM) Has A Somewhat Strained Balance Sheet
Feb 26Aster DM Healthcare's (NSE:ASTERDM) Shareholders Are Down 15% On Their Shares
Feb 11At ₹156, Is It Time To Put Aster DM Healthcare Limited (NSE:ASTERDM) On Your Watch List?
Jan 27Has Aster DM Healthcare Limited's (NSE:ASTERDM) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Jan 12Are Investors Undervaluing Aster DM Healthcare Limited (NSE:ASTERDM) By 30%?
Dec 28Here's What To Make Of Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital
Dec 13Trade Alert: The CEO of Aster Pharmacy Of Aster DM Healthcare Limited (NSE:ASTERDM), Jobilal Vavachan, Has Sold Some Shares Recently
Nov 28Is Aster DM Healthcare (NSE:ASTERDM) A Risky Investment?
Nov 27Shareholder Returns
ASTERDM | IN Healthcare | IN Market | |
---|---|---|---|
7D | 0.6% | -1.8% | -1.1% |
1Y | 15.3% | -6.9% | -3.4% |
Return vs Industry: ASTERDM exceeded the Indian Healthcare industry which returned -6.9% over the past year.
Return vs Market: ASTERDM exceeded the Indian Market which returned -3.4% over the past year.
Price Volatility
ASTERDM volatility | |
---|---|
ASTERDM Average Weekly Movement | 4.7% |
Healthcare Industry Average Movement | 4.9% |
Market Average Movement | 5.7% |
10% most volatile stocks in IN Market | 9.0% |
10% least volatile stocks in IN Market | 3.3% |
Stable Share Price: ASTERDM is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ASTERDM's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 25,806 | Mandayapurath Moopen | https://www.asterdmhealthcare.com |
Aster DM Healthcare Limited operates as a healthcare company in India and internationally. The company operates through Hospitals, Clinics, Retail Pharmacies, and Other segments. It provides primary, secondary, tertiary, and quaternary healthcare services through 29 hospitals, 121 clinics, 421 retail pharmacies, 17 laboratories, and 109 patient experience centers under the Aster, Medcare, and Access brands.
Aster DM Healthcare Limited Fundamentals Summary
ASTERDM fundamental statistics | |
---|---|
Market Cap | ₹104.35b |
Earnings (TTM) | ₹4.89b |
Revenue (TTM) | ₹108.56b |
21.6x
P/E Ratio1.0x
P/S RatioIs ASTERDM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ASTERDM income statement (TTM) | |
---|---|
Revenue | ₹108.56b |
Cost of Revenue | ₹70.69b |
Gross Profit | ₹37.87b |
Other Expenses | ₹32.98b |
Earnings | ₹4.89b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 9.84 |
Gross Margin | 34.89% |
Net Profit Margin | 4.51% |
Debt/Equity Ratio | 49.7% |
How did ASTERDM perform over the long term?
See historical performance and comparison